🔗 Share this article

This year's prestigious award in Physiology or Medicine was granted for transformative discoveries that illuminate how the body's defense network targets dangerous infections while sparing the healthy tissues.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—share this accolade.

Their work uncovered unique "security guards" within the immune system that eliminate rogue immune cells capable of harming the organism.

These findings are now paving the way for innovative treatments for autoimmune diseases and cancer.

The laureates will divide a monetary award worth 11 million Swedish kronor.

Crucial Discoveries

"The work has been decisive for comprehending how the body's defenses operates and the reason we don't all develop severe self-attack conditions," commented the head of the Nobel Committee.

The trio's studies address a core question: How does the immune system defend us from numerous infections while leaving our own tissues intact?

Our immune system employs white blood cells that scan for signs of infection, even viruses and germs it has never encountered.

Such cells utilize sensors—known as recognition units—that are generated randomly in a vast number of variations.

This gives the defense network the capacity to fight a wide array of threats, but the unpredictability of the mechanism inevitably produces white blood cells that can target the host.

Security Guards of the Immune System

Scientists earlier understood that some of these problematic white blood cells were eliminated in the immune organ—where immune cells develop.

The latest award honors the identification of regulatory T-cells—described as the immune system's "security guards"—which travel through the system to disarm other immune cells that attack the body's own tissues.

It is known that this mechanism malfunctions in autoimmune diseases such as juvenile diabetes, MS, and RA.

A Nobel panel added, "These discoveries have laid the foundation for a new field of research and accelerated the creation of innovative treatments, for example for cancer and immune disorders."

Regarding malignancies, T-regs block the body from attacking the tumor, so research are focused on lowering their numbers.

In self-attack disorders, experiments are exploring boosting regulatory T-cells so the organism is not under attack. A comparable approach could also be effective in minimizing the chances of organ transplant rejection.

Pioneering Studies

Professor Sakaguchi, from Osaka University, conducted tests on mice that had their immune gland extracted, causing self-attack conditions.

He showed that injecting defense cells from healthy mice could stop the illness—implying there was a mechanism for blocking immune cells from attacking the body.

Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an inherited autoimmune disease in mice and people that led to the identification of a genetic factor vital for how T-regs function.

"Their groundbreaking work has uncovered how the body's defenses is controlled by T-reg cells, stopping it from accidentally targeting the healthy cells," said a prominent physiology expert.

"This research is a remarkable example of how fundamental biological study can have far-reaching consequences for human health."